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SUMMARY
During the two-week period ending October 13, 1962, 62 cases of 
poliomyelitis, 52 paralytic, were reported to CDC through the telegraphic 
morbidity reporting system. The comparable two weeks in 1961 accounted for 
104 cases, 67 paralytic. Cumulative and seasonal totals for 1962 remain 
below those for any preceding year.
Twenty-one States reported cases during this time. Although case 
concentrations of recent orgin have not been noted in any of these States, 
further data on the cases noted in Illinois are presented.
Surveillance data on cases occurring within 30 days of vaccine 
administration is presented. A summary of reported cases of paralytic 
poliomyelitis occurring within 30 days of inactived vaccine since January 
1, 1961, is presented.
Isolates of non-polio enteroviruses reported from 23 States are 
presented. No specific type has predominated in 1962, although Coxsackie 
B-3 has been recovered by the greatest number of States reporting.
Clinical and laboratory detail on cases of paralytic poliomyelitis, 
from non-epidemic areas in 1962, reported as occurring within 30 days of 
receiving oral polio vaccine is appended. All cases since January 1, 1962 
are included. Reported paralytic cases among household contacts of oral 
vaccinees in non-epidemic areas are also presented.
1. CURRENT POLIOMYELITIS MORBIDITY TRENDS
A total of 62 cases of poliomyelitis, 52 paralytic, has been reported 
for the two week period ending October 13. Twenty-two of the paralytic cases 
occurred during the latter week. During the comparable weeks in 1961, 104 
cases, 67 paralytic, were reported.
Of the twenty-one States reporting cases for this period, Illinois 
with 9 cases, California with 7, and Texas with 6^  accounted for the largest 
number. No case concentrations of recent origin have been reported; however, 
because of the large number of cases noted in Illinois, a special report 
from this State is presented in Section 2.
The cumulative and six-week totals for 1962 and the preceding four 
years are shown in the tabulations below. The totals for 1962 remain well 
below those for any preceding year.
Polio (Cumulated Weekly) through 41st Week for Past Five Years
1962 1961 1960 1959 1958
Paralytic 522 661 1,752 4,515 2,156
Total 66 3 1,027 2,540 6,956 4,454
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Six-week Totals (36th thru 41st Week) for Past Five Years
1962
*-? o
1961 1960 1959 1958
Paralytic 154 • 244 662 1,687 1,048
Total 193 410 958 2,511 2,173
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During the two-week period ending October 13, Dr. Norman Rose, Chief, 
Bureau of Epidemiology, reported 9 cases of poliomyelitis, including 8 
paralytic. Seven of the paralytic cases were from Cook County.
A line listing of 1962 cases from Cook County on which specific data 
are available appears below. The latest reported case had onset on October
3. Two of the cases were designated as being outside of Chicago.
- • ■ . ■ . . .  ;  ■ ■
PARALYTIC POLIOMYELITIS IN COOK COUNTY - 1962
J fir'll J ' • \ foior : oil Vacc. Status Poliovirus
NO. Onset Age Race Sex IPV OPV Isolate
1 6/14 1 W F 0 — I
2 7/4 1 NW M 0 1 T > j / i’v S i
3 7/8 2 m F 1 - I
4 7/8 2 w F 0 ■
5 7/10 It 6 w - F 4 - I
6 7/13 4 Unk M S 0 - I
7 7/30 1 W F 1 - ! I
8 July 1 W M 0 - III
9 Unk* 1 ¥ M Unk 3 - III
10 Unk* 24 W M Unk I
11 8/4 4 NW F 0 - I
12 8/8 26 W F 2 - '• I Rising Titer
13 8/10 1 NW M 0 u -' -r I
14 8/10 15/12 nw M Unk - I
15 8/26 3 w ; M Unk - • I
16 9/7 17/12 NW M Unk — 9 * I
17 9/13 4 NW F 0 - i i. ■ I
18 9/15 10 W F 3 - -
19 10/3 8 nw M Unk -
* Reported in July
x..
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3. 1962 PARALYTIC CASES REPORTED TO PSU
Of the 522 cases of paralytic poliomyelitis reported through the 
week ending October 13, 501 had onset in 1962. The Poliomyelitis Surveillance 
Unit has received individual case forms on 396 of the 501 paralytic cases.
The vaccination status of the 396 paralytic cases by age group is shown 
below.
Paralytic Poliomyelitis by Age Group 
And Vaccination History Reported on PSU Forms 
(Through October 12, 1962)
Age
Group
Doses
0V
of Inactivated Vaccine 
1-2 V 3V 4+V Unk. Total Percent
0-4 130 34 11 12 10 197 49.7
5-9 34 10 12 20 2 78 19.7
10-14 17 4 9 4 2 36 9.1
15-19 10 2 5 3 0 20 5.1
20-29 18 6 3 3 2 32 8.1
30-39 11 4 0 2 1 18 4.5
40+ 11 1 0 _2 J L 15 3.8
TOTAL 231 61 40 46 18 396 100.0
PERCENT
DOSES 61.1 16.1 10.6 12.2 - 100.0
Of the 187 cases with known vaccination history in the 0-4 age group,
130 (70 percent) have not received any poliomyelitis vaccinations.
To date in 1962, the Poliomyelitis Surveillance Unit has received 
results of virological studies on 185 of the 396 paralytic cases. Poliovirus 
isolates have been recovered from 154 (83.2 percent) of the 185 cases. Of 
these, 119 are Type I, 2 are Type II, and 33 are Type III poliovirus. Isolates 
have been reported from the following States.
Poliovirus
State I II III Total
Alabama 2 0 0 2
Arizona 2 0 0 2
Arkansas 1 1 0 2
California 4 0 7 11
Colorado 1 1 0 2
D.C. 0 0 1 1
Georgia 2 0 1 3
Illinois 9 0 2 11
Kentucky 9 0 1 10
Louisiana 4 0 2 6
( r ma r i _c m_f n  11 r w i n st  n a r p )
Poliovirus
State I II III Total
Maryland 1 M O 0
d. ££ • • 5 ' 
1
Massachusetts 3 0 0 3
Michigan 4 > . 0 3 7
Minnesota 4 0 0 4
Mississippi 0 0 1 1
Montana 1 - 0
.
' Oyp.--■ irJtaxjl
Nebraska 0 0 1 1
New York 8 0 3 11
Ohio 5 0 4 9
Oregon 0 0 3 ‘IT. Ml 3:JV
Pennsylvania 4 .0 1 sc
Tennessee 1 0 0 l
Texas 51 0 2 53'
Utah f 1 0 0 1
Washington 0 0 1 l
£5.JL
West Virginia 1 0 o. 1/
Wyoming 1 _0 _0 l
TOTAL 119 2 33 154
r i ■ . • . I ri •
4. ROUTINE POLIOMYELITIS SURVEILLANCE - 1962
> ■' e.T5 >i m ■ sv i ■ ox erf
A. Cases with Onset within 30 Days of Vaccine (Inactivated)
(1) Currently Reported Cases
. ' •. ■ v 7 . \  P • >-» v •» . ; > '• n ' . | ’ - .■ *V | f | p» erri ' 0 i.*» J t. " • •. • . • i • ' v. • • • * . '• — . *• ' • •
During the two-week period ending October 13, one case of polio­
myelitis within 30 days following vaccination has been reported to the 
Poliomyelitis Surveillance Unit. This case, a 2 year-old male from Orange 
County, Florida, was vaccinated on July 26 and had onset of illness on 
August 12. He previously had received 3 doses of inactivated vaccine. The 
preliminary diagnosis was paralytic poliomyelitis with involvement of the 
right leg.
To date in 1962, 13 case reports of poliomyelitis within 30 days 
followint vaccination have been submitted to the Poliomyelitis Surveillance 
Unit. Ten of these have had paralysis. One case has exhibited correlation 
between site of injection and site of first paralysis.
(2) Summary Paralytic Poliomyelitis with Onset within 30 Days 
after IPV Adminis tration 1961-1962
During 1961, 28 "under 30 day paralytic cases" were reported to PSU 
and in 1962, through October 13, 10 "under 30 day paralytic cases".
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Of the 28 cases reported during 1961, 9 occurred in epidemic areas.
In each of the areas, community-wide OPV programs were carried out as an 
epidemic control measure. Seven of these were reported from Madison, Oneida 
and Onondaga Counties (Syracuse area), New York: two were reported from
Fulton County (Atlanta), Georgia. Of the ten cases reported during 1962, 
seven occurred in areas with known outbreaks. Five were from separate 
counties in Texas, one from Cambria County, Pennsylvania, and one from 
Mobile, Alabama. Outbreaks in each of the areas resulted in mass type- 
specific oral vaccine programs. One additional case from Washington State 
experienced transient paralysis; from this patient, Coxsackie B-5 was 
isolated from the stool.
Reported Paralytic Poliomyelitis 
’•Under 30-Day Cases” After IPV
No. of Cases
Epidemic Areas Coxsackie B-5 Non-Epidemic Areas Total
1961 9 1 18 28
1962 _7 _0 _3 10
16 1 21 38
The twenty-one cases reported from non-epidemic areas since January 1, 
1961, are from thirteen States. Type I poliovirus was isolated from 6;
Type III from 3.
Isolate
State No. of Cases I III
Alabama 1
Arkansas 1 1
California 4 2
Florida 1
Kentucky 1
Louisiana 2 1 1
Maryland 1 1
Michigan 2 1
New York 2
Ohio 1
Texas 2 1
Vermont 2
Wisconsin _! _  _i
TOTAL 21 6 3
Twelve of the twenty-one cases were under 5 years of age; three were 
adults. Only one of the cases had received four or more doses of IPV, 30 
days or more preceding onset.
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t o ,1V 2V 3V 4V 5V Total 0
: :• ro rj , ?; g v . *-■ 'iiit !t o r{oB v* a 1.
<1 2 l 0 . , 3
1-4 5 1 ; 3 '"tr f -Jp.i ■ 'i l * 7 9
5-9 3 1 4
10-14 ■ 1 1 2
15-19 0
20-29 8 ■ 0 : - ,0\U0l\
30-39 _2 JL U -- ?-j ■ __. . . 3
Total 9 5 4 2 1 21
There was no apparent clustering of cases in any particular interval
between the time of injection and the onset of disease. Three of the cases,
in fact, had onsets within four days after injection.
) . o , orA
Interval xn Days No. of Cases
0-4 I 3
5-9 4
10-14 4 -r
15-19 2
20-24 3
25-30 4
tiRun#., fjoftts m ? 00 ffSO’T*! ____1 -j\ rj i, / :  ul
•a v'- iwiTs i VG A. k.CtoCf 1. V*XiXc ar. ; x r ^ ’
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For seventeen of the cases, information regarding manufacturer of the 
vaccine given was available, for fifteen information regarding lot number 
was also provided. The vaccine derived from four manufacturers; a variety 
of lot numbers were recorded, only one lot was noted in connection with 
two cases. Both of the cases came from a single State. Only one case 
exhibited correlation between site of inoculation and site of first paralysis.
B. Cases with Onset within 30 Days of Vaccine (Oral)
Seven cases of paralytic poliomyelitis, occurring within 30 days 
following oral vaccine feeding, were reported to the Poliomyelitis Surveillance 
Unit during the two weeks ending October 13. Alabama , Massachusetts and 
Nebraska accounted for two each and Pennsylvania for one. The two cases from 
Mobile County, Alabama, had been fed Type I oral polio vaccine on September 
5 during a community oral vaccination program instituted because of a Type 
I poliomyelitis outbreak in the area. First symptoms of illness occurred 
12 and 13 days After vaccination. Type III oral polio vaccine had been 
given to the Massachusetts, Nebraska and Pennsylvania cases during community 
programs within 30 days before onsets of illness. Each of the cases had 
received Type I oral polio vaccine previously.
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A detailed line listing of the 7 cases appears below.
Doses Interval Type Virus Paralytic
State County Age Sex IPV Onset from OPV Fed Isolation Status
Alabama Mobile 4/12 M 0 9/18 13 I P
Alabama Mobile 17/12 M 0 9/17 12 I - P
Massachusetts Norfolk 4 M 4 7/2 26 III - P
^Massachusetts Bristol 7 M 5 6/15 14 III I P
Nebraska Lancaster 6 M 3 8/5-12 7-14 III - P
Nebraska Keya Paha 12 F 3 9/3 16 III Ill P
Pennsylvania Venango 4 M 4 6/6 8 III III P
*Type I O.P.V. administered 42 days before onset of illness. 
**No residual paralysis at 60 days.
Thus far in 1962, 45 cases occurring within 30 days of oral vaccination 
have been submitted to the Poliomyelitis Surveillance Unit on individual case 
forms. Twenty-four of these have occurred outside of epidemic areas. Of 
these 24, 3 have occurred within 30 days following type I feeding (one of 
which was non-paralytic), one following type II, and 20 within 30 days of 
type III administration.
5. ENTEROVIRUS SURVEILLANCE
A total of 318 non-poliomyelitis enterovirus isolates has been 
reported to the Poliomyelitis Surveillance Unit through October 16. 
Twenty-three States have accounted for these, as shown in Table 5. As 
compared to 1961, when isolates of Coxsackie B-5 were reported in large 
numbers, there is no predominant enterovirus type evident. Coxsackie B-3 
has been recovered in 13 of the 23 States reporting.
Non-Polio Enterovirus Isolations from 1962 Specimens
ECHO Coxsackie
State 4 9 14 22 Other* B-2 B-3 B-5 Other* Unsp. Total Reported By
Alabama 3 2 1 6 T. Hosty
California 2 17 1 6 5 1 1 1 11 45 E. Lennette and P. Wehrle
Connecticut 17 6 6 3 32 E. Borman and G. Hsiung
Florida 2 1 2 5 • J. Bond
Hawaii 1 2 7 36 46 J. Enright
Illinois 1 2 1 2 1 . 7
|£ t'
H. Shaughnessy
Kansas 1 6 3 7 9 26 7 C. Hunter
Kentucky 1 Ut. 1 C. Todd
Louisiana 11 3 1 , 6 a 5 26 G. Hauser
Maryland 1 3 3 6 5 18 J. Joseph
Massachusetts 1 1 2 o. 4 R. MacReady and J. Daniels
Michigan 6 1 7 5 3 22 G. Agate
Minnesota 2 1 3 H. Bauer
Missouri % & 1 1 • 2 I. Adams
New Hampshire • ' r~. 2 2 R. Miliner
New Jersey 1 3 1 5 M. Goldfield and W. Dougherty
New York 1 1 5 2 1 6 16 I. Albrecht
North Carolina 1 1 L. Madry
Ohio 2 4 5 4 6 21 C. Croft
Pennsylvania 3 3 K. Hummeler and I. Gratch
Texas 4 12 1 1 18 J. Irons and A. Behbehani
Virginia 3 3 E. Foxhall
Washington 1 1 1 1 1 5 K. Berquist and W. Giedt
318
♦Specific types include 15 Coxsackie A-4 and 12 A-5 in Hawaii, and 5 A-9 in Michigan. 
A variety of single isolates of other ECHO and Coxsackie types have been reported.
Figure 1 CURRENT U.S. POLIO INCIDENCE
COMPARED WITH YEARS I957\ 1959 and 1961 
April -  December, by week
Data Provided by National Office of Vital Statistics and Communicable Disease Center
Table 1
TREND OF 1962 POLIOMYELITIS INCIDENCE
State ' 
and
Cumula­
tive
Cases Reported to CDC 
For Week Ending
Six
Week
Comparable Six 
Week Totals i n —-
Region 1962 9/8 9/l5 9/22 9/29 lo/6 10/13 Total 1961 1960 1959.
UNITED STATES 
Paralytic 522 25 22 22 33 30 22 154 244 662 1687
Nonparalytic 101 4. 5 5 7 4 2 27 113 197 647
Unspecified 40 1 3 2 2 4 12 53 99 177
Total 663 30 30 29 42 34 28 193 410 958 2511
NEW ENGLAND
Paralytic 7 - - - 2 — — 2 9 43 117
Total 7 - - - 2 — — 2 17 58 137
Maine - — - — — — — _ 2 23 50
New Hampshire - - - - - - - — - — **
Vermont - - - - - — — 3 6 4
Massachusetts 6 - — — 2 _ — 2 8 5 58
Rhode Island - - - — — — — 1 8 3
Connecticut 1 - - - - - - - 3 16 20
MIDDLE ATLANTIC
Paralytic 48 4 2 1 2 2 3 14 89 116 225
Total 68 5 2 1 4 2 4 18 159 173 325
New York 52 1 2 - 4 2 2 11 125 89 199
New Jersey 6 - - 1 - - - 1 10 32 57
Pennsylvania 10 4 - - - - 2 6 24 52 69
EAST NORTH CENTRAL
Paralytic 60 4 1 3 5 9 5 27 35 121 179
Total 87 6 4 5 1 0 1 0 7 42 55 187 455
Ohio 17 2 2 — - 1 - 5 17 40 74
Indiana 16 2 — 2 4 1 2 11 5 53 45
Illinois 36 1 1 2 3 8 1 16 8 40 123
Michigan 12 - 1 - 2 - 3 6 13 34 196
Wisconsin 6 1 - 1 1 - 1 4 12 20 17
WEST NORTH CENTRAL
Paralytic 21 - 4 1 2 2 - 9 9 45 263
Total 31 - 4 1 2 2 - 9 23 75 438
Minnesota 6 — — - — — - - 2 21 109
Iowa 5 — — — — — — — 8 10 103
Missouri 9 — — — 2 - — 2 6 19 133
North Dakota 3 — — — — — — - 2 7 10
South Dakota 1 — 1 — — — — 1 1 1 3
Nebraska 7 — 3 1 — 2 — 6 4 8 33
Kansas — — - — — - - - 9 47
Table 1 (Continued
State
and
Kegion
Cumula­
tive
1962
Cases Reported to CDC 
For Week Ending 
9/8 9/15 9/22 9/29 10/6 10/13
Six
Week
Total
Comparable Six 
Weeks Totals In 
1961 1960 1959
SOUTH ATLANTIC
Paralytic 48 2 1 5 3 4 3 18 38 159 312
Total 54 2 1 6 3 5 4 21 51 182 376
Delaware - - - - - - - - — — 3
Maryland 1 - - - 1 - - 1 5 87 25
D.C. 2 - 1 - - - - 1 2 2 3
Virginia 8 - - - - - - - 4 15 88
West Virginia 6 1 - - - - - 1 10 13 82
North Carolina 10 1 - 1 - 3 2 7 6 21 88
South Carolina 6 - - 1 - 1 - 2 20 28 28
Georgia 14 - - 4 1 1 2 8 1 9 33
Florida 7 - - - 1 - - 1 3 7 26
EAST SOUTH CENTRAL
Paralytic 51 4 1 4 9 2 3 23 13 23 187
Total 60 4 3 4 9 2 3 25 30 85 232
Kentucky 24 1 - 1 4 - 1 7 8 54 48
Tennessee 8 1 2 - - - - 3 12 20 117
Alabama 22 2 1 3 5 - — 11 1 5 44
Mississippi 6 - - - - 2 2 4 9 6 23
west south central
Paralytic 214 9 7 8 7 6 4 41 19 49 145
Total 275 11 9 12 9 8 6 55 38 69 244
Arkansas 12 - 1 1 2 2 1 7 7 12 92
Louisiana 20 3 - 4 1 - 1 9 14 8 24
Oklahoma 16 2 2 - 1 3 1 9 1 8 30
Texas 227 6 6 7 5 3 3 30 16 41 98
Mountain
Paralytic 10 - - - - - 2 2 1 14 28
Total 14 - 1 - - - 2 3 4 24 48
Montana 4 - - - - - 1 1 - 3 -
Idaho 2 - - - - - - — 2 - 1
Wyoming 2 - 1 - - - - 1 - 10 -
Colorado 2 - - - - 1 1 - 9 12
New Mexico — — - - - - - - - 1 10
Arizona 3 — - - - - - - 1 — 19
Utah 1 — - - — — - - 1 1 3
Nevada - - - - - - - - - - 3
pacific
Paralytic 63 2 6 - 3 5 2 18 31 92 231
Total 67 2 6 - 3 5 2 18 33 105 256
Washington 2 - 1 - - - - 1 6 10 80
Oregon 5 - - - - - - - 3 7 49
California 60 2 5 — 3 5 2 17 22 88 120
Alaska — — — — - — - — — 6
Nawaii - - - - - - - - 2 - 1
territory
Puerto Rico 11 — - - - 1 - 1 1 53 1
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SUPPLEMENT TO CPC POLIOMYELITIS SURVEILLANCE REPORT NO. 270
U.S. Department of Health, Education, and Welfare
Public Health Service Bureau of State Services
COMMUNICABLE DISEASE CENTER 
Atlanta 22, Georgia
Case Summaries of Poliomyelitis Associated 
With the Administration of Oral Vaccine
October 24, 1962
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On September 20, the Surgeon General released a technical report 
to the medical profession entitled "The Association of Cases of Polio­
myelitis with the Use of Type III Oral Poliomyelitis Vaccine". In this 
report were listed 16 reported cases of poliomyelitis occurring within 
30 days of administration of oral polio vaccine. These cases had been 
reviewed in detail by the Surgeon General»s Oral Poliomyelitis Vaccine 
Advisory Committee.
Twelve of these cases were unanimously accepted by the Committee as 
"compatible" with a vaccine relationship. Each of these 12 cases had 
experienced an illness clinically diagnosed as paralytic poliomyelitis 
and had evident residual paralysis; additionally, the available laboratory 
findings were not inconsistent wi^h a vaccine relationship. The remaining 
four cases were "excluded5* by the Committee on the grounds that there was 
no significant residual paralysis or that laboratory findings were incom­
patible with a vaccine relationship.
The present supplement includes brief summaries of the pertinent, 
clinical and laboratory data of the 16 cases listed in the Surgeon 
Generalfs report. In addition 4 cases from Nebraska, reported subsequent 
to the preparation of the Surgeon General*s report, were reviewed by the 
Committee on October 2, These cases were all considered to be "compatible". 
Summaries of these are also included herein.
Special comment should be made regarding the virological and 
serological studies.
The laboratory studies, usually initiated by the State health 
department, hospital or university laboratories, have been or are being 
confirmed and extended by the Enterovirus Laboratory of the Communicable 
Disease Center under Dr. Henry Gelfand. These studies include, when 
possible, virus isolations on monkey kidney cells, virus characterization 
using the modified Wecker and McBride tests, a search for other than polio­
viruses using poliomyelitis neutralized aliquots in suckling mice, Hela 
and monkey kidney cell systems. Neutralizing antibody levels using the 
metabolic inhibition test technique are being determined.
Interpretation of the laboratory data must, as pointed out by the 
Advisory Committee, be interpreted with caution. The designation of "wild­
like" or "vacd. ne-like" is ascertained by the modified Wecker and McBride 
tests. These tests are used to demonstrate slight antigenic differences 
between polio virus strains of the same type. Since the vaccine strains 
may, after a period of intestinal multiplication, show a shift in the 
antigenic characteristics of the viruses, the finding of either "wild-like" 
or "vaccine-like" strains might be expected in an individual fed the vaccine. 
Further, since each of the individuals in this group of cases had received 
the oral vaccine, it is to be anticipated that many of these persons would 
be excreting poliovirus. Isolation of the virus from a stool specimen 
therefore establishes only that the individual contracted the intestinal 
infection; it does not necessarily prove that the observed illness was 
caused by the virus.
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A. Cases of Reported Paralytic Poliomyelitis Occurring Within 30 Days of the 
Administration of Oral Poliomyelitis Vaccines in Nonepidemic Areas
January 1 to October 13, 1962
Type I Vaccine
Onset Interval from Mfgr.
Case
No. Age Sex
Doses
IPV
: First 
Symptom
OPV
I
(Days) 
II III
Virus
Recovered
Antibody
Response
& Lot 
(Coded)
Committee^-
Appraisal
NY 1*** 3 M 2 5/29 23 mm I I A12 Excluded
Tenn 1 25 M 1 8/30 10 -
Type,
I
II Vaccine
I All Compatible
Ohio 1 2 F 2 2/23 >90 8 
Type
III
III Vaccine
- B2- Excluded
Hich 1 23 M 4 7/16 76 - 17 III Ill B34 Compatible
Mich 2 36 F 0 7/20 - - 22 III III B36 Compatible
Neb 1 18 F 5 7/1 34 - 7 III - A3- Compatible
Neb 2 51 M 0 7/16 51 - 22 0 - A3- Compatible
Neb 3 37 M 0 7/23 43 - 15 - - A3- Compatible
Neb 4 50 F 4 8/16 61 - 19 (**) (**) A31 Compatible
Neb 5 57 M 0 8/17 53 - 23 (**) (**) C31 Compatible
Neb 6 6 M 3 8/5-8/12 52* - 9* (**) (**) A3- Compatible
Neb 7 13 F 3 9/3 41 - 16 III (**) C3- Compatible
NY 2 49 M 0 6/18 >90 - 26 0 II & III B35 Compatible
Ohio 2 16 M 0 6/8 43 - 15 - - B3- Compatible
Ohio 3 36 M 0 7/15 - - 21 0 I & III B34 or 6 Compatible
Ore 1 48 F 0 5/5 34 - 7 III III B31 Compatible
Ore 2 39 M 0 5/21 50 - 23 III - B31 Compatible
Ore 3*** 6 M 0 5/25 54 - 27 I & III - B31 Excluded
Ore 4 52 M 0 6/26 52 - 19 III Ill B31 Compatible
Wash 1 6 M 4 6/12 
Officially Reported
37
but Not
5 1  I B31 
Yet Considered by the Committee
Excluded
Mass 1 4 M 4 7/2 44 - 26 - - C11&A32 To be con­
sidered
Mass 2 7 M 5 6/15 42* 14* I - Al- To be con­
sidered
Pa 1*** 4 M 4 6/6 55 8 III B6- To be con­
sidered
B. Cases of Reported Poliomyelitis Occurring Within 60 Days of 
Household Contact of Oral Polio Vaccinees in Nonepidemic Areas 
January 1 to October 13, 1962
Case No. Age Sex
Doses
IPV
Onset 
First 
Symp tom
Interval
I
Contact 
(Days) 
II
Fed OPV 
III
Virus Antibody 
Recovered Response
Ohio Bj_ x 6/12 M 0 6/8 . . 33 III No Spec.
Mass *** 42 F 4 6/26 55* - 25* No Specimen
Mass b2 18/12 M 0 6/19 59* - 18 I
Approximate ***No Residual Paralysis
**In Process xNot Strictly a Household Case
• • t 535 -3“ i
Nev York - 1 (Case 1 - Surgeon General*s Report)
Onset Interval From
Doses First OPV (days) Virus Studies Committee 
Age Race Sex IPV Symptom I II III Type Character Appraisal
3 W M 2 5/29 23 - - I Wild-Like Excluded , r
This 3 year-old white male was noted to be walking with a limp, favoring the 
left leg, during the last week of May. There had been no known antecedent 
illness. -
The child had received 2 injections of inactivated polio vaccine. He was 
fed oral polio vaccine type I on May 6.
On examination there was weakness of the left gluteus maximus, knee extensors, 
and hamstrings. By June 13, there was no trace of a limp and no muscle 
weakness could be demonstrated.
C.S.F.: No examination performed
Stool:(June 22) Type I poliovirus Wild-like by modified Wecker and McBride 
Tests <,f,3 -■
Serum Neutralizing Antibodies Days After Onset
» \ «■ , ■ *' ; - O dt Cj _C - a ‘ J
V . * •
1 1 1 1 5 ■i c  v* i atC
€£ & siO
•s b v  / a S Type I 1:6 1:10 ''1:25
#:JWe / .'A-0
Tennessee - 1 (Case 2 - Surgeon General»s Report)
 ^>3 / ! > ** 
Doses
Onset
First
Interval From ^
OPV (davs) Virus Studies Committee
Age Race Sex IPV Symptom I II III Type Character Appraisal
25 W M 1 8/30 10 - P I Wild-Like Compatible
On August 24, the patient first became ill with abdominal pain and diarrhea, 
lasting 24 hours. He then felt well until August 30 when he noted pain in 
the back of the neck, in the back and in both legs. The pain persisted, and 
by September 1, there was also fever, severe headache, and weakness of the 
right leg. He was hospitalized on September 2,
• ; O " . . .
The patient had received one dose of inactivated polio vaccine in 1960. He 
received type I oral polio vaccine on August 20,
On hospital admission, September 2, there was nuchal rigidity, weakness of 
the right plantar flexors, complete loss of function of right toe dorsi- 
flexors, and weakness of right knee flexor and extensors. No sensory deficit
bio ih tavoi a icM x  .enocT l «I*V
-4-
was demonstrable. The paralysis of the right leg has persisted without 
change, the same findings being present as of mid-October.
C.S.F.: (September 2) 471 cells, (44% polys, 56% mononuclears)
Stool: (September 5) Type I poliovirus Wild-like by modified Wecker 
and McBride Tests.
Serum Neutralization Antibodies: Days After Onset
2 16
Type I 8 256
n J! 16 512
u u p 256 >512
Ohio - 1 (Case 3 - Surgeon General*s Report)
Age Race 
2 N
Doses
Onset
First
Interval From 
OPV (davs) Virus Studies Committee
Sex IPV Symptom I II III Type Character Appraisal
ExcludedF 2 2/23 > 90 8 III
This child was reported to the Poliomyelitis Surveillance Unit as having 
onset of a clinical illness leading to a persistent asymetric paralysis 8 
days after receiving type II oral polio vaccine. A type III virus was 
recovered from the stool. The child had not received the type III vaccine; 
no type III oral polio vaccine had in fact been licensed at the time of this 
child*s illness.
This case was excluded as being not related to the administered vaccine.
Michigan - 1 (Case 4 - Surgeon General*s Report)
Doses
Onset
First
Interval From 
OPV (days) Virus Studies Committee
Age Race Sex IPV Symptom I II III Type Character Appraisal
23 W M 4 7/16 76 17 III Wild-like Compatible
This 23 year-old, married, white laborer was hospitalized on July 20 because 
of weakness of the left leg.
The patient was on National Guard maneuvers at Camp Grayling, Michigan, and 
felt well until July 15, when he complained of vague malaise, sore throat, 
diffuse myalgia, frontal headache and anorexia. He had two loose stools 
that morning. Examination by the camp physician revealed a temperature of
-5-
101°F. and slight meningismus. It was thought he had "intestinal flu" and 
he returned to duty. On July 17, he felt subjective stiffness of the neck 
and experienced "sweats and chills." On July 18, examination revealed 
meningismus and pain in the left calf. In addition, the left leg was noted 
to be weak and he walked with a limp. On July 20, he was admitted to an 
Air Force hospital.
He reports having received three doses of inactivated polio vaccine in 1959 
and a booster in 1960, although records confirm only two of the four doses.
He was fed type I oral polio vaccine on April 25, 1962, and type III on 
June 23, 1962. On June 30, 16 days before onset of the present illness, he 
had experienced fever, malaise and anorexia. His physician administered 
penicillin; the following day he felt well. The past history is otherwise 
no t r ema rlcab 1 e .
On hospital admission, he was afebrile. There was no nuchal rigidity. Weak­
ness was noted in the quadriceps, anterior tibial and calf muscles on the left. 
The left patellar and left Achilles tendon reflexes were markedly diminished.
No sensory changes were found. On examination, October 22, the paresis of 
the left leg was still persistent. He could walk with the aid of a brace.
Cerebrospinal Fluid Cell Count % Polys % Mononuclear Protein
7-18-62 ' 129 95% 5% 29 mg %
7-30-62 14 14% 86% 27 mg %
Stool: (August 14) Type III poliovirus Wild-like by modified Wecker and
McBride Tests.
Serum Neutralizing Antibodies
, 1 ; • . • > 
Days After Onset
5 14
Type I 1:512 1:512
Type II 1:512 1:512
Type III 1:256 1:512
Michigan - 2 (Case 5 - Surgeon General*s Report)
Age Race Sex
Doses
IPV
Onset
First
Symptom
Interval from 
OPV (Days)
I II III
Virus Studies 
Type Character
Committee
Appraisal
36 W F 0 7/20 22 III Vaccine-like Compatible
This 36-year-old housewife and mother of an eleven-year-old child was ad­
mitted to the University Hospital, Ann Arbor, on July 31, with a fever of 
102.2° and flaccid paralysis of the left shoulder and arm. On July 20, she 
had noted onset of malaise and backache for 48 hours, accompanied by a low 
grade fever. On July 22 and 23, she felt perfectly well and was active.
On July 24, she noted fever of 101.6° and return of the symptoms mentioned 
above, and was seen by her physician, who diagnosed "flu" and prescribed a
-6-
sulfonamide. On July 26, she noted weakness in her left arm. During the 
ensuing days the fever persisted but she did not consult her physician again 
until July 30, when the paralysis was confirmed and hospital admission 
arranged.
This woman had received no inactivated vaccine. She was fed type III oral 
polio vaccine on June 28.
On examination, there was flaccid paralysis of the left shoulder and left 
arm, as well as some weakness of the right arm. The left triceps and left 
biceps tendon reflexes were absent. No sensory deficit was noted. A muscle 
evaluation performed by a physical therapist on August 1 revealed:
Left Right
Deltoid Trace + Poor +
Biceps Poor Fair +
Triceps Poor Poor
On examination, October 22, the patient had severe, but not complete paralysis 
of the muscle groups of the left shoulder and arm.
C.S.F.: (July 30) 72 cells (25% polys, 15% mononuclear), protein 64 rag%>
(Repeat 74 mg$)
Stool: (August 2) Type III poliovirus Vaccine-like by the modified Wecker 
and McBride Tests.
Serum Neutralizing Antibodies
Type I 
" II 
" III
Days After Onset
16 26
1:128 1:256
<1:8 < 1:8
1:64 1:572
Nebraska - 1 (Case 6 - Surgeon General*s Report)
Onset Interval From 
Doses First OPV (days) 
Age Race Sex IPV Symptom I II III
Virus Studies 
Type Character
Committee
Appraisal
18 W F 5 7/1 3 4 - 7  III Compatible
This 18 year-old white female student had the onset of headache, general 
malaise, anorexia, nausea, vomiting and low grade fever on July 1. These 
symptoms persisted and by July 9, low back pain and weakness of both legs 
was also noted. There was stiffness of the neck and demonstrable weakness 
of the left leg on July 11. The patient was hospitalized on July 17.
-7-
She had previously received five doses of inactivated polio vaccine, the 
latest in 1960. The patient was fed type I oral polio vaccine on May 27, 1962 
and type III on June 24.
U . ' '• ■' ' P ' ' iff? . _ ' '
On examination, loss of function of the left quadriceps and left hip muscles 
was evident as well as some weakness of right quadriceps. The deep tendon 
reflexes were absent in the left leg. The weakness was still present on 
examination in mid-September and the left thigh was 2^” smaller in circumfer­
ence than the right thigh.
.5 . £ > ; * ; .  £ , £/■ ’ > o . \ £ o c t
C.S.F.,: (August 17) 61 W.B.C. (11% polys, 89% mononuclear)
• • . ■ . • ' . . , ....
Stool: (July 23) Type III poliovirus Strain characterization under study. 
Serum Neutralizing Antibodies Days After Onset
.. 24 36 69 71
Type I 1:720 >1:512 1:360 >1:512
» II 1:256 >1:512 1:256 >1:512
” III 1:512 >1:512 1:512 1:512
Nebraska - 2 (Case 7 - Surgeon General*s Report) quox - 61
Onset Interval From - •-
Doses First OPV (days) Virus Studies Committee 
Sex IPV Symptom I II III Type Character Appraisal
v" I ' •
M 0 7/16 51 22 0 - : Compatible
' ‘ ; S’? ' ' ' •; :■ '
This 51 year-old white male, tire distributor was admitted to the hospital on 
July 23 with a seven day history of ’’sore muscles” . On July 19, there was 
low grade fever, weakness of the left leg and general malaise.
The patient had received no inactivated polio vaccine. He received type I 
oral polio vaccine on May 27 and type III on June 24.
Age Race 
51 W
On hospital admission marked weakness of the left quadriceps, hamstrings and 
anterior tibial was noted. The deep tendon reflexes were absent in the 
left lower extremity. No sensory abnormalities were found. In September 
he required a brace and cane for proper ambulation because of a left foot 
drop.
C.S.F.; (July 19) No cells; ’’normal” protein
XjL.I. V IMF, ‘IT yf
Stool: (July 30) No virus isolated
Serum Neutralizing Antibodies
Type I 
” II 
" III
Days After Onset
7 12
1:256 1:360
<1:8 <1:8
1:180 1:128
-8-
Nebraska - 3 (Case 8 - Surgeon General*s Report)
Doses
Onset
First
Interval From 
OPV (days) Virus Studies Committee
Age Race Sex IPV Symptom I II III Type Character Appraisal
37 W M 0 7/23 43 15 No Specimen Compatible
This 37 year-old white, male, truck driver was well until July 23 when the
onset of sore throat, fever, chills, and backache were noted. On July 28, 
the patient found difficulty driving because of inability to lift his right 
foot. He measured his own temperature that day and found it to be 102° F. 
The above symptoms persisted and the patient consulted his physician.
The patient had received no inactivated polio vaccine. He received type 
I oral polio vaccine on June 10 and type III on July 8.
When examined on August 2, there was marked weakness of the right let, 
spasm on straight leg raising and absent deep tendon reflexes bilaterally. 
No sensory deficit was demonstrated. He was hospitalized on August 5, but 
left against medical advice five days later. In mid-September there was 
persistance of the weakness of the right leg, especially the quadriceps. 
Muscle wasting in this limb as well as a foot drop and inability to hyper- 
abduct the right shoulder were also found at this time.
C.S.F.: (August 5) No cells; protein determination not done.
Stool: No specimen obtained
Serum Neutralizing Antibodies Days After Onset
49
Type I 1:256
!f II 1:16
" III 1:256
Nebraska - 4 (Not in Surgeon General’s Report)
Doses
Onset
First
Interval From
OPV (days) Virus Studies Committee
Age
50
Race Sex IPV Symptom I II III Tvpe Character Appraisal
W F 4 8/16 61 - 19 Compatible
This 50 year-old housewife was well until August 16 when she noted aching 
in both legs. The following day there was fever to 102° F. and general 
malaise without nausea or vomiting. Examination by her physician on 
August 22 revealed no evident physical abnormalities. On August 24 she awoke 
with complete paralysis of her left leg and was admitted to the hospital.
-9-
The patient received 4 doses of inactivated polio vaccine, the last in 1958 
or 1959. She was fed oral polio vaccine type I on June 16 and type III on 
July 28.
On admission, she exhibited flaccid paralysis of the left lower extremity.
The deep tendon reflexes were absent in that leg. No sensory abnormality 
was noted. The other extremities were normal. The spinal fluid demonstrated 
a pleocytosis (as recorded below). The paralysis did not progress and the 
patient had a low grade fever during the first seven hospital days. By 
September 15 the ability to flex the knee 15° to 20° and to wiggle the toes 
on the left were the only demonstrable signs of return of function. Exami­
nation on October 9 revealed persistant weakness with wasting of the 
involved extremities.
C.S.F.: (August 24) 35 W.B.C. (20$ polys) 
Stool; (August 26) In process
Serum Neutralizing Antibodies Days After Onset
n 42
Type I 1:256 1:512
11 II 1:64 1:256
!* III 1:8 1:256
Nebraska - 5 (Not in Surgeon General*s Retort)
Doses
Onset
First
Interval From
OPV (days) Virus Studies Committee
Age Race Sex IPV Symptom I II III Type Character Appraisal
57 W M 0 8/17 53 - 23 Compatible
This 57 year-old white male auto parts dealer became ill on August 17 with 
mild headache, general malaise and an urge to void. On August 23, he noted 
an unusual degree of arm fatigue after unloading a truck of antifreeze. His 
physician examined him on August 24 and noted no abnormalities. That evening 
the patient developed fever and on the following morning, fell on arising 
because of weakness of the left leg.
The patient had received no inactivated polio vaccine. He received type I 
oral polio vaccine on June 24 and type III on August 5.
On examination at the time of hospital admission on August 26, the temperature 
was 101° and the pharynx was injected. There was slight movement of the 
quadriceps on the left and good movement on the right; nevertheless, he was 
unable to raise either leg. He was also unable to move the left foot. There 
were no sensory abnormalities. The flaccid paralysis on the left progressed 
and he was transferred to an Omaha hospital August 29.
-10-
Examination on October 3 revealed a continued flaccid paralysis of both 
lower extremities, strikingly hypoactive reflexes, marked muscular wasting 
bilaterally and no demonstrable return of function.
C.S.F. White Cells Protein
8/26 7 83 mg %
8/29 - 39 mg % (Traumatic puncture; cells
were not counted)
Stool; (August 31) In process
Serum Neutralizing Antibodies Days After Onset
40
Type I >1:512
ss II 1:64
" H I  1:256
-11-
Onset Interval from
Doses First OPV (Days) Virus Studies Committee 
Age Race Sex IPV Symptom 1 XT III Type Character Appraisal
6 W M 3 8/5-8/12 49-56 - 7-14 - - Compatible
This six-year-old white male developed headache, low grade fever and general 
malaise, without other constitutional symptoms, sometime between August 5 
and August 12. This was 7 to 14 days after receiving type III oral polio 
vaccine. Within two days, the child began to limp, favoring his right leg, 
and he complained of pain in the right lower calf and ankle. The pain 
lasted 3-4 days; however, the limp persisted. (He is one of seven children; 
the mother is not an accurate historian.)
The patient had received three doses of inactivated polio vaccine, the last 
in 1958. He received oral polio vaccine, type I on June 17, type II on 
September 23, and type III on July 29.
The patient was first seen on September 24 by an orthopedic surgeon for 
evaluation. Definite weakness of several muscle groups in the right leg 
was noted, as well as measurable atrophy of the right calf muscles. There 
was a right foot drop as well. When examined on October 1, weakness of hip 
flexors and adductors and foot flexors on the right was noted. The right 
Achilles and patellar reflexes were strikingly hypoactive. The circum­
ference of the right mid-thigh was 3/4 inch less than the left, and the 
right mid-calf 1/2 inch less than the right. The patient walked with a limp.
C.S.F. : No examination performed.
Stool: (10/1/62) In Process.
Serum Neutralizing Antibodies Days After Onset
_£2_
Nebraska - 6 (Not in Surgeon General's Report)
Type I 
Type II 
Type III
1:256
1:128
1:256
-12-
Onset Interval from
Nebraska - 7 (Not in Surgeon General's Report)
Doses First OPV (Days) Virus Studies Committee
Race Sex IPV Symp tom I II III Type Character Appraisal
W F 3 9/3 41 16 III Compatible
This 12-year-old white female was well until she developed fever, severe 
occipital headache, nausea, and anorexia on September 3. The headache dis­
appeared by the following day, the fever persisted, and she developed pain 
in her right thigh and calf. She experienced increasing difficulty in 
moving her right leg.
She was first seen by her local physician and hospitalized locally on 
September 8. At that time, the thigh and calf pain was still present, as 
well as low grade fever. The patient had no leg motion at hip, knee, or 
ankle. The deep tendon reflexes were absent in the right leg but normal 
elsewhere. She had no nuchal rigidity but exhibited a tripod sign. There 
were no sensory disturbances. Hip X-rays were normal and no cells were 
found in the cerebrospinal fluid. The physician diagnosed the illness as 
poliomyelitis and transferred her to an Omaha hospital on September 11.
The past history is non-contributory except that the patient fell from her 
bicycle on August 28, bruising her right thigh. She experienced some dis­
comfort that day, but felt well the following day and until the onset of 
her illness on September 3. She had received three doses of inactivated 
polio vaccine in 1957 and 1958. On July 24, she received type I oral polio 
vaccine, and on August 18, type III.
On admission to the Omaha hospital, the physical findings were as described. 
The cerebrospinal fluid was interpreted as normal (see below), as were hip 
X-rays. Cystogram revealed an atonic bladder. A myelogram revealed a 
filling defect at a level of the 4th thoracic vertebra, which was felt could 
be due to a bony spike projecting into the canal. An exploratory laminectomy 
was performed on September 17, but no abnormalities were found. She was 
discharged September 24.
Examination on October 10 revealed persistent marked weakness of the right 
leg, a right foot drop, and wasting of the right thigh and calf. She was 
able to stand and take a few unsteady steps.
C.S.F. Cells No. polys No, mononuclear Protein
8/11 0 Not done
8/14 3 2 1 50 mg °L
Stool: (September 26) Type III Poliovirus, Strain characterization in process.
Serum Neutralizing Antibodies Days After Onset
Type I 
Type II 
Type III
(In Process)
-13-
Onset Interval from
Doses First OPV (Days) Virus Studies Committee 
Age Race Sex IPV Symptom _I II III Type Character Appraisal
49 W M 0 6/18 190 - 26 .• 0 - Compatible
This 49-year-old white male was well until June 18 when he developed coryza, 
malaise, fatigue, frontal headache, and low back pain. On June 19, the 
patient began to experience fever and chills. There was extension of the 
pain to the upper back and neck. On June 21, the patient felt nauseated 
and vomited several times; the back pain was less severe, but he noted 
stiffness of the neck and left leg weakness, which caused him to fall on 
several occasions. He experienced no pain or cramping in his extremities.
By June 22, the left leg weakness had progressed so that the patient was 
unable to stand; there was weakness of the left arm, and left hip pain.
He had received no inactivated poliomyelitis vaccine. He received oral 
vaccine, type I in August 1961, and type III on May 23, 1962. The past 
history was otherwise not remarkable.
On examination, the temperature was 102°, and there was nuchal rigidity.
There was weakness of the left arm and leg with absent deep tendon reflexes. 
Pain in the left hip was present with any movement. No sensory abnormality 
was noted. Following admission, weakness of the right arm and leg developed 
on June 24, and the deep tendon reflexes became hypoactive. The patient 
became confused and his behavior was described as paranoid for several days. 
Weakness of the diaphragm and intercostal muscles was first noted on June 25, 
and progressed such that by June 27, a tracheostomy was necessary, and he 
was placed in a Drinker respirator. Bilateral weakness of cranial nerves 
VII and X was noted on July 4. By July 16, the patient tolerated brief 
periods out of the respirator. Examination on October 22 revealed weakness 
of all extremities, more severe on the left, and persistent paresis of the 
left hemi-diaphragm.
New York - 2 (Case 9 - Surgeon General's Report)
j * i .4 4-j.• • *■ 331Zoh :.id OJ sun ' c
C.S.F. 0 •bm>o5 irxw ■ 
Total
J • * *T '; f. T '
Date White Cells Polys Lymphs RBC's Protein (mg%)
June 22 • ” 70 4 ,VT 2 12 :7, 58 0 78
June 25 157 80 77 0 77
July 2 55 5 50 0 140
July 9 8 0 8 0 330
August 2 2 0 2 3 158
Stools: (June 22 - July 
30 and 40 days
2) No virus 
after feeding
isolated from four specimens between
tOd'.T-'K’ ' • •" } .. ;
Serum Neutralizing Antibodies _____Days After Onset of Illness
4 10 19 32 46 56
Type I 1:64 1:256 1:64 1:256 1:64 1:256
Type II <1:3 <1:8 1:128 1:128 1:128 1:90
Type III 1:32 1:256 1:1034 1:720 1:520 1:360
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Ohio - 2 (Case 10 - Surgeon General's Report)
Doses
Onset
First
Interval from 
OPV (Days) Virus Studies Committee
Race Sex IPV Svmp tom I II Ill Type Character Appraisal
W M 0 6/8 43 - 15 No Specimen Compatible
This 16-year-old white male high school student developed diffuse myalgia, 
particularly of the back and shoulders, on June 3, following swimming. On 
June 9, there was a low grade fever. Over the next six days, he noted pro­
gressive weakness of the right leg. He was admitted to the hospital on 
June 15.
The patient had received no inactivated polio vaccine. He received type I 
oral polio vaccine on April 26, and type III on May 24. He complained of 
headache and mild neck stiffness on May 25 and 26, and during the first week 
in June, he noted tightness in both thighs without systemic illness.
On admission, the temperature was 99^ *, the neck was supple and there was 
obvious weakness of the right leg. The patient was unable to raise the 
right leg, nor was he able to flex or extend the right foot. Deep tendon 
reflexes were absent in that extremity. No sensory abnormalities were 
demonstrated. The temperature spiked to 1033 for the first two days and 
then remained normal.
Examination on August 22 revealed continued weakness of the right lower leg 
muscles and partial weakness of the right quadriceps with atrophy of these 
muscles.
C.S.F. No. Cells 7o Polys 7o Mononuclear Protein
June 15 103 6 94
June 16 50 14 86 33 mg %
Stool; No specimen obtained. 
Serum: No studies performed.
15-
Ohio - 3 (Case 11 - Surgeon General'1s Report) f It. O Sli
Doses
Onset
First
Interval from 
OPV (Days) Virus Studies Committee
Age Race Sex IPV Symp tom I II III Type Character Appraisal
36 w M 0 7/15 21 ‘ , 0 Compatible
This 36-year-old white male moving van driver was well until July 15 when 
he began to have loose stools, which continued for six days. On July 18, 
he developed a severe headache, unrelieved by salicylates, which persisted 
for 24 hours. The patient felt a chill on the morning of July 19, and 
experienced sharp pain in the lower back which radiated to both legs. He 
vomited once that night. He noted weakness of both legs on July 20. The 
headache and backache persisted but his neck was not stiff. He also had 
difficulty voiding.
The patient had received no inactivated poliomyelitis vaccine. He received 
oral polio vaccine, type III, on June 24. Members of his family had received 
type I oral vaccine one month earlier.
On admission, he was afebrile. There was paresis of both legs, with absent 
ankle reflexes; both patellar reflexes were intact. The deep tendon reflexes 
were normal in both arms; the abdominal reflexes were absent bilaterally.
The cranial nerves were intact, the neck was supple, and there was no sensory 
deficit. The paresis progressed after admission. By July 22, the patellar 
reflexes were absent bilaterally, and he was thought to have an atonic bladder. 
He was placed in a respirator on July 23 because of respiratory embarrassment 
and difficulty swallowing. A tracheostomy was performed on July 28.v:
In mid-September, he exhibited persistent paralysis of both lower extremities 
though there was seme movement of the left foot. Intermittent respiratory 
assistance was still required. Bladder function had returned to normal three 
weeks after onset of illness.
C.S.F. : (July 21) Clear, 316 cells (198 RBC's, 113 Polys, 5 Lymphs),
Protein 50 mg 7».
Stool: (July 23) No virus isolated.
(July 25) No virus isolated. .
Serum Neutralizing Antibodies Days After Onset
8 15 23
Type I 
Type III
1:360 1:2048 1:2048
<1:128 1:360 1:512
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Onset Interval from
Doses First OPV (Days) Virus Studies Committee 
Age Race Sex IPV Symptom 1 II III Type Character Appraisal
48 W F 0 5/5 34 - 7 III Vaccine-Like Compatible
This 48-year-old white female, the wife of a State highway department engineer, 
became ill on May 5 with aching legs and excessive fatigue. On May 6, she 
experienced cramps in both legs. Symptoms of headache, low grade fever and 
low backache were first noted May 8 and persisted for several days. There 
was difficulty in standing because of leg weakness on May 10, as well as 
perineal pain on voiding. By May 13, she was unable to move either lower 
extremity and was admitted to the hospital.
The patient had received no inactivated polio vaccine. She received oral 
polio vaccine, type I on April 1 and type III on April 28.
On admission, the temperature was 100°; there was some nuchal rigidity and 
flaccid paralysis of both lower extremities with absent deep tendon reflexes. 
Some spasm of the lumbar muscles was noted. There was no sensory abnormality. 
The temperature returned to normal on the third hospital day; however, the 
right arm became increasingly weak during this period. The patient required 
frequent catheterization for the first two weeks in the hospital. On July 27, 
examination revealed muscle atrophy of both legs. All muscle groups in the 
legs demonstrated either absent or poor function; in addition, there was 
weakness and atrophy of the right forearm flexors and right thenar muscles.
No sensory defects were demonstrated.
C.S.F. Total Cells 7o Polys % Mononuclears Protein
May 13 323 227, 787. 95 mg 7.
June 6 0 - - 145 mg %
Stool: (May 15) Type III Poliovirus, vaccine-like by the modified Wecker
and McBride Tests.
Oregon - 1 (Case 12 - Surgeon General's Report)
Serum Neutralizing Antibodies
Type I 
Type II 
Type III
Days After Onset
7
>1:512
>1:512
1:180
12
>1:512
>1:512
1:512
37
>1:512
>1:512
1:1024
-17-
Onset Interval From
Doses First OPV (days) Virus Studies Committee 
Age Race Sex IPV Symptom I II III Type Character Appraisal
39 W M 0 S/21 50 - 23 III Wild-like Compatible
Oregon - 2 (Case 13 - Surgeon General*s Report)
This 39 year-old white male insurance company executive was well until May 
21 when he developed a generalized myalgia following physical exertion. On 
May 22, he had difficulty voiding accompanied by suprapubic pain. There 
was a feeling of "numbness” in the right leg, which was also noted to be 
weak, and low back pain.
The patient had received no inactivated polio vaccine. He received type I 
oral polio vaccine on April 1 and type III on April 28.
On admission to the hospital on May 24, the temperature was 100^ , there 
was rhinitis and injection of the pharynx. There was weakness of the right 
lower leg and right toe flexors. The patellar reflex was hypo-active and 
the Achilles reflex was absent on the right. The cremasteric and abdominal 
reflexes were absent bilaterally. Sharp and dull differentiation was poor 
on admission but was normal by May 31. There were no other sensory deficits. 
The temperature ranged from 100° to 102° during the first 72 hours after 
admission and then remained normal. Cystometrogram on May 25 was normal.
Pain in the back and right leg muscles persisted for several days. The 
patient was transferred to a Veterans Administration Hospital on June 12, 
at which time there was weakness and tenderness to palpation of the right 
quadriceps and gastrocnemius. On July 30, examination revealed poor function 
of gastrocnemius and anterior tibial muscles, fair to poor function of the 
quadriceps and hamstrings and fair hip abductor and adductor function on the 
right. Weakness of the toe flexors was the only abnormality on the left. 
There was atrophy of the right calf and right thigh. Sensation was normal.
C.S.F.; (May 24) RBC 211, WBC 51 (35% polys, 65% mononuclear), protein 93mg%
Stool; (June 4) Type III poliovirus Vaccine-like by the modified Wecker 
and McBride Tests.
Serum Neutralizing Antibodies Days After Onset
13 28
Type I 1:256 1:256
” III 1:64 1:32
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Oregon - 3 (Case 14 - Surgeon General's Report)
Onset Interval from
Doses First OPV (Days) Virus Studies Committee
Age Race Sex IPV Symptom I II III Type Character Appraisal
6 W M 0 5/25 54 27 I Wild-like Excluded
III Vaccine-like
This 6-year-old white male was well until May 23 when he fell, striking the 
back of the head and sustaining a superficial laceration. On May 25, the 
boy complained of headache and a stiff neck. He was found to have a tempera­
ture of 102°.
At age six months, the patient was diagnosed as having H. influenza menin­
gitis. Three right sided convulsions accompanied this illness. There had 
been no other significant illnesses and no residual neurologic difficulties. 
He had received no inactivated polio vaccine. He was fed type I oral polio 
vaccine on April 1 and type III on April 28. Hospitalized on May 28, the 
temperature was 100^°, but after 24 hours returned to normal. There was 
nuchal rigidity but no lateralizing or localizing signs, weakness or sensory 
abnormalities. The skull X-ray was normal. Discharged on June 5, he was re­
admitted the same day because of complaints of pain in the arms and legs 
on exertion. Examination showed nuchal rigidity and a depressed right 
patellar reflex.
Examination on July 28 revealed no sensory or motor impairment; however, the 
right patellar reflex was still hypoactive, the right calf was 1/2 inch 
smaller in circumference than the left.
C . S.F. Red Cells White Cells % Polys Mononuclears Protein
May 28 50 30 11 89 44 mg %
June 5 1447 26 12 88 11 mg %
Stool: (June 8) Type I poliovirus, wild-like, by modified Wecker and McBride
tests. Type III poliovirus,vaccine-like, by modified Wecker and 
McBride tests.
Serum Neutralizing Antibodies Days After Onset
12 31
Type I 1:512 1:512
Type II 1:32 1:32
Type III 1:90 1:180
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Oregon - 4 (Case 15 - Surgeon General*s Report)
Onset Interval From ;.i. —Z.~i ~
Doses First OPV (days) Virus Studies Committee
Age Race Sex IPV Symptom I II III Type Character Appraisal
52 W M 0 6/26 52 ~- ~ 19 III Vaccine-like Compatible
This 52 year-old white male entomologist developed a sore throat, without 
other symptoms, on June 14. This persisted for about one week. On June 
26, he noted numbness of the right foot. On awakening on June 27, there 
was a generalized muscle stiffness, low backache and malaise. That after­
noon, he noted headache and weakness in both legs. He was hospitalized 
on June 28.
He had received no inactivated polio vaccine. He received type I oral polio 
vaccine on May 5 and type III on June 7. In preparation for foreign travel 
he was vaccinated for smallpox on June 23 (with a strong immune reaction) 
and received 1 cc of polyvalent influenza vaccine.
.o
On admission, the temperature was 994 and there was weakness of both lower 
extremities, more severe on the right. The pharynx appeared normal and 
there was no nuchal rigidity. The right patellar reflex was absent and 
the Achilles reflex hypoactive. Reflexes in the left leg and arms were 
normal. Over the following 48 hours, the weakness progressed so that by 
June 30, there was respiratory difficulty, disturbance of bladder function 
and weakness of the arms and abdominal muscles as well as the legs. He 
also exhibited disorientation and poor emotional control. At no time were 
there sensory deficits. One month later, on examination, the patient*s 
voice was of nasal quality; weakness of the palate was noted. There was 
a weakness of the right superior oblique which had been first noted on July 
9. Decreased excursion of the diaphragm and inter-costal weakness was 
evident. Muscle function of both legs was poor, the left more than the 
right. Both legs showed muscular atrophy. There was weakness and atrophy 
of the right triceps. There was no sensory abnormality. Discharged from 
the hospital in early October there was no change in paralytic status.
C.S.F.: (June 28) 278 cells (48 RBCTs, 42 polys, 188 mononuclears) 
protein 73 iag % . *
Stool: (June 30) Type III Vaccine-like poliovirus by the modified Wecker 
and McBride Tests.
Serum Neutralizing Antibodies Days After Onset
4 14
Type I 1:256
" II <-1:8
" III 1:32
1:128
<1:8
1:145
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Onset Interval from
Washington - 1 (Case 16 - Surgeon General*s Report)
Race Sex
Doses
IPV
First 
Symp tom
OPV (Days)
I II III
Virus Studies 
Type Character
Committee
Appraisal
W M 4 6/12 37 - 5 I Indeterminate Excluded
This 6-year-old white male was well until June 12 when he was noted to be 
"sleepy" and "not acting right." Subsequently, he developed intermittent 
fever and pain in the left upper leg. He was hospitalized June 12.
The patient had received four doses of inactivated poliomyelitis vaccine, 
the most recent in 1961. He was fed type I oral polio vaccine on May 6 and 
type III on June 7. On admission, there was stiffness of the neck and back, 
spasm of the hip and knee flexors, and weakness of the left lower extremity. 
Muscle evaluation on June 28 revealed abnormalities of the left lower ex­
tremity as follows: Quadriceps, good; hip adductor, fair+, Gastrocnemius,
anterior tibial and foot flexors, fair-. Repeat evaluation July 2 revealed 
identical findings. On August 2, repeat examination by an orthopedic con­
sultant revealed only weakness of the flexors of the left great toe.
C.S.F. : (June 12) 22 cells (all mononuclear), protein 24 mg %.
Stool: (June 18) Type I poliovirus, indeterminate, by modified Wecker and
McBride Tests.
Serum Neutralizing Antibodies Days After Onset
4 24
Type I 32 256
Type II <8 <8
Type III <8 <8
The information contained in these summaries has been drawn from several 
sources of information and, of necessity, has been edited and condensed for 
presentation. Comment regarding possible error or significant omission 
would be most welcome. Corrections and additional information, as it becomes 
available, will be published in subsequent PSU Reports.
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